by Öner Tulum, William Lazonick, and Ken Jacobson This is the first installment of a three-part series on the scalability of mRNA vaccine production. The current article focuses…
Tag: William Lazonick
#7. Scaling of COVID vaccine manufacturing: What are the problems that can occur in the early stages?
by Öner Tulum, William Lazonick, and Ken Jacobson In March 2020, as a number of developers announced COVID-vaccine candidates that would begin clinical trials, vaccine manufacturers around the…
#6. Scaling of COVID vaccine manufacturing: Does the CEO understand the extraordinary complexities involved?
by Öner Tulum, William Lazonick, Ken Jacobson, and Ellen Chappelka During an interview on December 18, 2020, Moderna CEO Stéphane Bancel revealed his “Never Again Plan,” which…
#5. Scaling of COVID vaccine manufacturing: What manufacturing activities are involved and why are they so difficult?
by Öner Tulum, William Lazonick, and Ken Jacobson In March and April 2021, Americans received as many as four million doses a day of COVID-19 vaccines, far…
Stock Buybacks Stand in the Way of Biden’s Infrastructure Plan
Hedge fund managers are pushing American firms to play Wall Street games instead of investing in technologies of the future. China doesn’t have that problem.
#3. Where do those COVID vaccines come from?
by Öner Tulum, William Lazonick, and Ken Jacobson The success of the worldwide COVID-vaccine rollout depends on decisions regarding the utilization of available production capacity made both independently…
#2. How effectively is global capacity being utilized? Is there any idle capacity to press into service?
by Öner Tulum, William Lazonick, and Ken Jacobson Despite vaccines’ significant public-health benefits, sales of all vaccines accounted for less than four percent of $872 billion in prescription-drug…
#1. Is there enough production capacity available for the vaccine supply to meet urgent demand in 2021?
by Öner Tulum, William Lazonick, and Ken Jacobson As COVID-19 vaccines receive regulatory approval, the world has a powerful weapon to fight the coronavirus. But at what pace…
4 Burning Questions on the Global Vaccine Rollout
Warnings of “corruption and incompetence coming together,” as economists William Lazonick and Öner Tulum study the race to end the pandemic.
As the pandemic continues, the rich are getting richer than ever before — and economists are getting concerned
“If the COVID-19 pandemic has produced winners and losers, then young Canadian billionaire Tobias Lütke is definitely a winner. Since the start of the pandemic in March, the 40-year-old CEO of Ottawa-based e-commerce company Shopify Inc., has watched his personal…
